search
Back to results

Tympanostomy Tubes Versus Eustachian Tube Dilation

Primary Purpose

Eustachian Tube Dysfunction, Eustachian Tube Dysfunction of Left Ear, Eustachian Tube Dysfunction of Right Ear (Diagnosis)

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Reducing symptoms of Eustachian tube dysfunction
Sponsored by
Columbia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Eustachian Tube Dysfunction focused on measuring Eustachian Tube Dysfunction, Eustachian Tube balloon dilation, Eustachian Tube dilation, Tympanostomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Determined to have chronic Eustachian tube dysfunction of at least 3 month duration based on a score of ≥ 14.5 on the Eustachian tube dysfunction questionnaire-7 (ETDQ-7), regardless of tympanogram status

Exclusion Criteria:

  • Insurance that does reimburse for ET balloon dilation
  • Patients with acute upper respiratory infection
  • Tympanic membrane perforation
  • Known middle ear disease such as cholesteatoma, acute otitits media, history of head and neck radiation, history of cleft palate, cystic fibrosis, ciliary dyskinesia, nasopharyngeal mass and patulous eustachian tube

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Tympanostomy with tubes

    Eustachian tube (ET) dilation

    Arm Description

    Tympanostomy with pressure equalization tube placement with Ventilation (Tympanostomy) Tubes

    Eustachian tube (ET) dilation with ACCLARENT AERA® Eustachian Tube Balloon Dilation System

    Outcomes

    Primary Outcome Measures

    ETDQ-7 score
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    ETDQ-7 score
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    ETDQ-7 score
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    ETDQ-7 score
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    ETDQ-7 score
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Tympanogram
    The patient's post-op tympanogram will be recorded to compare to follow-up visits.
    Tympanogram
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Tympanogram
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Tympanogram
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Tympanogram
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.

    Secondary Outcome Measures

    Full Information

    First Posted
    March 19, 2019
    Last Updated
    February 6, 2023
    Sponsor
    Columbia University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03886740
    Brief Title
    Tympanostomy Tubes Versus Eustachian Tube Dilation
    Official Title
    Tympanostomy Tubes Versus Eustachian Tube Dilation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2023
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Difficulty enrolling
    Study Start Date
    May 2019 (Anticipated)
    Primary Completion Date
    August 2021 (Anticipated)
    Study Completion Date
    August 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Columbia University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The objective of this study is to determine whether tympanostomy with pressure equalization tube placement or Eustachian tube (ET) dilation is superior at reducing symptoms of patients with ET dysfunction. Given the apparent promise of Eustachian tube dilation and the lack of head to head comparison to the more traditional tympanostomy tube, this study seeks to compare them in a head to head manner in order to assess superiority in regards to ETDQ-7 and tympanogram improvements.
    Detailed Description
    The eustachian tube serves to ventilate and equalize middle ear pressure; clear secretions from the middle ear with mucociliary action; and protect the middle ear from sounds, pathogens, and secretions from the nasopharynx. First described anatomically by Eustachius in 1563 and with its exact function worked out a century later, Valsalva realized in 1703 that its opening was dynamic, not static, and described the namesake maneuver to expel pus from the middle ear into the external auditory canal. By the mid 18th century, multiple authors had attempted Eustachian tube catheterization and by the early 19th century, catheterization with irrigation and air insufflation had been described.(1) This shows how Eustachian tube dilation has been a known treatment for centuries, despite its relative obscurity prior to this decade. ET dysfunction is a common diagnosis many patients receiving care from an otologist or otolaryngologist receive. Dysfunction can be broken down into dilatory, which is caused by inflammation such as a virus, baro-challenge induced such as in scuba divers or those taking flights and patulous, which is of unclear etiology.(2) Symptoms are thought to include but are not limited to ear fullness, the sensation that the ear is underwater, otalgia, muffled hearing, tinnitus, autophony and ear popping amongst others. Clear diagnostic criteria are not present, though it is generally felt that a combination of symptoms and objective findings on otoscopy or tympanogram are enough to support the diagnosis. Many have resorted to using the Eustachian Tube Dysfunction Questionnaire-7 which is a validated symptom driven assessment, although it is only moderately associated with objective measures of ET dysfunction. (3,4) The only population-based study looking at prevalence used otoscopy, tympanogram and audiometry to estimate that it affects 0.9% of adults.(5) Unfortunately, there is currently no gold standard for treatment of ET dysfunction. The only randomized control study of medical treatments showed no impact of nasal steroids on ET dysfunction.(6) The most common surgical option is a tympanostomy tube, which has been used since the 1950s for both middle ear effusions and ET dysfunction.(7) Tympanostomy tubes can alleviate tympanic membrane retraction, atelectasis and effusion, although they do not address the underlying etiology of the ET dysfunction. Numerous nonrandomized and or noncontrolled studies have showed improvement in symptoms with tympanostomy tube placement. Depending on the study and the definition, 70-100% improvement has been reported. Despite this, high-level evidence for tympanostomy tube efficacy in ET dysfunction remains lacking.(8) Adenoidectomy has also been proposed as a way to improve ET function, but not surprisingly, most studies have shown that it only helps if the adenoids are found to be abutting or obstructing the torus tubarii.(9,10) Furthermore, these studies focus on children, and the adenoid pad is not likely to be a contributing factor in most adults. Eustachian tube balloon dilation recently came back into the mainstream beginning with the 2010 study by Ockermann et al. which showed the procedure was safe and produced good results in a small cohort. Numerous studies since then have shown efficacy, including two separate multicenter randomized controlled trials published in 2017 and 2018. Both of these showed statistically and clinically significant superiority of ET balloon dilation over control as measured by improvement in ETDQ-7 and tympanogram type at up to 1 year. (11,12,13)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Eustachian Tube Dysfunction, Eustachian Tube Dysfunction of Left Ear, Eustachian Tube Dysfunction of Right Ear (Diagnosis), Eustachian Tube Dysfunction of Both Ears (Diagnosis)
    Keywords
    Eustachian Tube Dysfunction, Eustachian Tube balloon dilation, Eustachian Tube dilation, Tympanostomy

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    One arm will be treated with tympanostomy with pressure equalization tube placement and the other with Eustachian tube (ET) dilation. Their Eustachian Tube Dysfunction Questionnaire-7 scores will be collected over time and compared.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Tympanostomy with tubes
    Arm Type
    Experimental
    Arm Description
    Tympanostomy with pressure equalization tube placement with Ventilation (Tympanostomy) Tubes
    Arm Title
    Eustachian tube (ET) dilation
    Arm Type
    Experimental
    Arm Description
    Eustachian tube (ET) dilation with ACCLARENT AERA® Eustachian Tube Balloon Dilation System
    Intervention Type
    Procedure
    Intervention Name(s)
    Reducing symptoms of Eustachian tube dysfunction
    Intervention Description
    One of two methods of reducing Eustachian Tube dysfunction will be performed and the Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) scores will be compared
    Primary Outcome Measure Information:
    Title
    ETDQ-7 score
    Description
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Time Frame
    Baseline
    Title
    ETDQ-7 score
    Description
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Time Frame
    6-weeks
    Title
    ETDQ-7 score
    Description
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Time Frame
    3-months
    Title
    ETDQ-7 score
    Description
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Time Frame
    6-months
    Title
    ETDQ-7 score
    Description
    The questionnaire contains 7 questions and total score will be divided by 7 to get mean score. Each visit will be averaged individually.
    Time Frame
    1-year
    Title
    Tympanogram
    Description
    The patient's post-op tympanogram will be recorded to compare to follow-up visits.
    Time Frame
    Baseline
    Title
    Tympanogram
    Description
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Time Frame
    6-weeks
    Title
    Tympanogram
    Description
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Time Frame
    3-months
    Title
    Tympanogram
    Description
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Time Frame
    6-months
    Title
    Tympanogram
    Description
    The patient's post-op tympanogram will be compared to their pre-op tympanogram.
    Time Frame
    1 year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Determined to have chronic Eustachian tube dysfunction of at least 3 month duration based on a score of ≥ 14.5 on the Eustachian tube dysfunction questionnaire-7 (ETDQ-7), regardless of tympanogram status Exclusion Criteria: Insurance that does reimburse for ET balloon dilation Patients with acute upper respiratory infection Tympanic membrane perforation Known middle ear disease such as cholesteatoma, acute otitits media, history of head and neck radiation, history of cleft palate, cystic fibrosis, ciliary dyskinesia, nasopharyngeal mass and patulous eustachian tube
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ana Kim, MD
    Organizational Affiliation
    Columbia University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    9081287
    Citation
    Feldmann H. [The Eustachian tube and its role in the history of otology. Images from the history of otorhinolaryngology, presented by instruments from the collection of the Ingolstadt German History Museum]. Laryngorhinootologie. 1996 Dec;75(12):783-92. doi: 10.1055/s-2007-997676. German.
    Results Reference
    background
    PubMed Identifier
    26347263
    Citation
    Schilder AG, Bhutta MF, Butler CC, Holy C, Levine LH, Kvaerner KJ, Norman G, Pennings RJ, Poe D, Silvola JT, Sudhoff H, Lund VJ. Eustachian tube dysfunction: consensus statement on definition, types, clinical presentation and diagnosis. Clin Otolaryngol. 2015 Oct;40(5):407-11. doi: 10.1111/coa.12475. No abstract available.
    Results Reference
    background
    PubMed Identifier
    22374681
    Citation
    McCoul ED, Anand VK, Christos PJ. Validating the clinical assessment of eustachian tube dysfunction: The Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Laryngoscope. 2012 May;122(5):1137-41. doi: 10.1002/lary.23223. Epub 2012 Feb 28.
    Results Reference
    background
    PubMed Identifier
    28949806
    Citation
    Teixeira MS, Swarts JD, Alper CM. Accuracy of the ETDQ-7 for Identifying Persons with Eustachian Tube Dysfunction. Otolaryngol Head Neck Surg. 2018 Jan;158(1):83-89. doi: 10.1177/0194599817731729. Epub 2017 Sep 26.
    Results Reference
    background
    PubMed Identifier
    1526050
    Citation
    Browning GG, Gatehouse S. The prevalence of middle ear disease in the adult British population. Clin Otolaryngol Allied Sci. 1992 Aug;17(4):317-21. doi: 10.1111/j.1365-2273.1992.tb01004.x.
    Results Reference
    background
    PubMed Identifier
    21576556
    Citation
    Gluth MB, McDonald DR, Weaver AL, Bauch CD, Beatty CW, Orvidas LJ. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 2011 May;137(5):449-55. doi: 10.1001/archoto.2011.56.
    Results Reference
    background
    PubMed Identifier
    4842776
    Citation
    Pappas JJ. Middle ear ventilation tubes. Laryngoscope. 1974 Jul;84(7):1098-117. doi: 10.1288/00005537-197407000-00004. No abstract available.
    Results Reference
    background
    PubMed Identifier
    25029951
    Citation
    Llewellyn A, Norman G, Harden M, Coatesworth A, Kimberling D, Schilder A, McDaid C. Interventions for adult Eustachian tube dysfunction: a systematic review. Health Technol Assess. 2014 Jul;18(46):1-180, v-vi. doi: 10.3310/hta18460.
    Results Reference
    background
    PubMed Identifier
    15126745
    Citation
    Nguyen LH, Manoukian JJ, Yoskovitch A, Al-Sebeih KH. Adenoidectomy: selection criteria for surgical cases of otitis media. Laryngoscope. 2004 May;114(5):863-6. doi: 10.1097/00005537-200405000-00014.
    Results Reference
    background
    PubMed Identifier
    1089852
    Citation
    Bluestone CD, Cantekin EI, Beery QC. Certain effects of adenoidectomy of Eustachian tube ventilatory function. Laryngoscope. 1975 Jan;85(1):113-27. doi: 10.1288/00005537-197501000-00009.
    Results Reference
    background
    PubMed Identifier
    28940574
    Citation
    Poe D, Anand V, Dean M, Roberts WH, Stolovitzky JP, Hoffmann K, Nachlas NE, Light JP, Widick MH, Sugrue JP, Elliott CL, Rosenberg SI, Guillory P, Brown N, Syms CA 3rd, Hilton CW, McElveen JT Jr, Singh A, Weiss RL Jr, Arriaga MA, Leopold JP. Balloon dilation of the eustachian tube for dilatory dysfunction: A randomized controlled trial. Laryngoscope. 2018 May;128(5):1200-1206. doi: 10.1002/lary.26827. Epub 2017 Sep 20.
    Results Reference
    background
    PubMed Identifier
    29912819
    Citation
    Meyer TA, O'Malley EM, Schlosser RJ, Soler ZM, Cai J, Hoy MJ, Slater PW, Cutler JL, Simpson RJ, Clark MJ, Rizk HG, McRackan TR, D'Esposito CF, Nguyen SA. A Randomized Controlled Trial of Balloon Dilation as a Treatment for Persistent Eustachian Tube Dysfunction With 1-Year Follow-Up. Otol Neurotol. 2018 Aug;39(7):894-902. doi: 10.1097/MAO.0000000000001853.
    Results Reference
    background
    PubMed Identifier
    30620688
    Citation
    Anand V, Poe D, Dean M, Roberts W, Stolovitzky P, Hoffmann K, Nachlas N, Light J, Widick M, Sugrue J, Elliott CL, Rosenberg S, Guillory P, Brown N, Syms C, Hilton C, McElveen J, Singh A, Weiss R, Arriaga M, Leopold J. Balloon Dilation of the Eustachian Tube: 12-Month Follow-up of the Randomized Controlled Trial Treatment Group. Otolaryngol Head Neck Surg. 2019 Apr;160(4):687-694. doi: 10.1177/0194599818821938. Epub 2019 Jan 8.
    Results Reference
    background

    Learn more about this trial

    Tympanostomy Tubes Versus Eustachian Tube Dilation

    We'll reach out to this number within 24 hrs